Set Analyses:
Advanced Search

Advanced Search

 
Search By
Section (entire)
for


 
or upload a file of gene symbols


Category   Symbol Source: HGNC EntrezGene Ensembl GeneCards RNA genes CroW21
GIFtS

TP53 Gene

protein-coding   GIFtS: 80
GCID: GC17M007565

tumor protein p53

 Explore 594 diseases affiliated with
TP53 via our new
 Human Malady Compendium 
Biological research products
for TP53
    

(According to 1HGNC, 2Entrez Gene,
3UniProtKB/Swiss-Prot, 4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc, 7Ensembl, 8DME, 9miRBase, and/or 10fRNAdb)
About This Section

This gene clusters with an RNA gene
Subcategory (RNA class): lncRNA

Quality score for the ORGUL clustered with this gene is 3

Aliases
Tumor Protein P531 2     BCC72
LFS11 2 5     TRP532
P532 3 5     Cellular Tumor Antigen P532
Antigen NY-CO-132 3     P53 Tumor Suppressor2
Phosphoprotein P532 3     Transformation-Related Protein 532
P532 3 5     Tumor Suppressor P533

External Ids:    HGNC: 119981   Entrez Gene: 71572   Ensembl: ENSG000001415107   OMIM: 1911705   UniProtKB: P046373   
ORGUL members:         
NONCODE:n335267 n337087 n343020    

Export aliases for TP53 gene to outside databases

Previous GC identifers: GC17P008026 GC17M008311 GC17M007514 GC17M007772 GC17M007512 GC17M007465


(According to Entrez Gene, Tocris Bioscience, Wikipedia's Gene Wiki, PharmGKB,
UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL)
About This Section

Entrez Gene summary for TP53:
This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization
domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby
inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are
associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative
splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms.
Additional isoforms have also been shown to result from use of alternate start codons (PMIDs: 12032546, 20937277).
(provided by RefSeq, Feb 2013)

UniProtKB/Swiss-Prot: P53_HUMAN, P04637
Function: Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the
physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to
negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes
is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and
FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF is involved in
activating oxidative stress-induced necrosis; te function is largely independent of transcription. Induces the
transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in
TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation.
Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to
DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from
some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth
suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis

summary for TP53:
p53 (aka TP53) is a transcription factor whose protein levels and post-translational modification state
alter in response to cellular stress (such as DNA damage, hypoxia, spindle damage). Activation of p53 begins
through a number of mechanisms including phosphorylation by ATM, ATR, Chk1 and MAPKs. MDM2 is a ubiquitn
ligase that binds p53 and targets p53 for proteasomal degradation. Phosphorylation, p14ARF and USP7 prevent
MDM2-p53 interactions, leading to an increase in stable p53 tetramers in the cytoplasm. Further
modifications such as methylation and acetylation lead to an increase in p53 binding to gene specific
response elements. p53 regulates a large number of genes (>100 genes) that control a number of key tumor
suppressing functions such as cell cycle arrest, DNA repair, senescence and apoptosis. Whilst the activation
of p53 often leads to apoptosis, p53 inactivation facilitates tumor progression; inactivating p53 mutations
occur in over 50% of cancers.

Gene Wiki entry for TP53 (P53)


(According to GeneLoc and/or HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to UCSC (hg19) and Ensembl (release 69), Regulatory elements and Epigenetics data according to QIAGEN, SABiosciences, and/or SwitchGear Genomics)
About This Section
RefSeq DNA sequence:
NC_000017.10  NC_018928.1  NT_010718.16  
Regulatory elements:
   SABiosciences Regulatory transcription factor binding sites in the TP53 gene promoter:
         CREB   C/EBPbeta   Sp1   ARP-1   
         Other transcription factors

SwitchGear Promoter luciferase reporter plasmids (see all 4): TP53 promoter sequence
   Search SABiosciences Chromatin IP Primers for TP53

Epigenetics:
QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat TP53


Genomic Location:
Genomic View: UCSC Golden Path with GeneCards custom track

Entrez Gene cytogenetic band: 17p13.1   Ensembl cytogenetic band:  17p13.1   HGNC cytogenetic band: 17p13.1

TP53 Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)
TP53 gene location

GeneLoc information about chromosome 17         GeneLoc Exon Structure

GeneLoc location for GC17M007565:  view genomic region     (about GC identifiers)

Start:
7,565,097 bp from pter      End:
7,590,863 bp from pter
Size:
25,767 bases      Orientation:
minus strand
ORGUL member locations:
Legend (see complete legend)

  • n343020
  • n337087
  • n335267
7571719 7581291 7590863 chr17

(According to 1UniProtKB, HORDE, neXtProt, Ensembl, and/or Reactome, Modification sites according to 2PhosphoSitePlus, Specific Peptides from DME, Protein expression images according to data from SPIRE MOPED and PaxDb, RefSeq according to NCBI, PDB rendering according to OCA and/or Proteopedia, Recombinant Proteins from EMD Millipore, R&D Systems, GenScript, Enzo Life Sciences, OriGene, Novus Biologicals, Sino Biological, ProSpec, and/or Uscn,
Biochemical Assays by EMD Millipore, R&D Systems, OriGene, GenScript, Cell Signaling Technology, Enzo Life Sciences, and/or Uscn, Ontologies according to Gene Ontology Consortium 01 Mar 2013 and Entrez Gene, Antibodies by EMD Millipore, R&D Systems, GenScript, Cell Signaling Technology, OriGene, Novus Biologicals, Thermo Fisher Scientific, Abcam, and/or Uscn)
About This Section

UniProtKB/Swiss-Prot: P53_HUMAN, P04637 (See protein sequence)
Recommended Name: Cellular tumor antigen p53  
Size: 393 amino acids; 43653 Da
Cofactor: Binds 1 zinc ion per subunit
Subunit: Interacts with AXIN1. Probably part of a complex consisting of TP53, HIPK2 and AXIN1 (By similarity). Binds
DNA as a homotetramer. Interacts with histone acetyltransferases EP300 and methyltransferases HRMT1L2 and CARM1, and
recruits them to promoters. In vitro, the interaction of TP53 with cancer-associated/HPV (E6) viral proteins leads to
ubiquitination and degradation of TP53 giving a possible model for cell growth regulation. This complex formation
requires an additional factor, E6-AP, which stably associates with TP53 in the presence of E6. Interacts (via
C-terminus) with TAF1; when TAF1 is part of the TFIID complex. Interacts with ING4; this interaction may be indirect.
Found in a complex with CABLES1 and TP73. Interacts with HIPK1, HIPK2, and TP53INP1. Interacts with WWOX. May interact
with HCV core protein. Interacts with USP7 and SYVN1. Interacts with HSP90AB1. Interacts with CHD8; leading to recruit
histone H1 and prevent transactivation activity (By similarity). Interacts with ARMC10, BANP, CDKN2AIP, NUAK1,
STK11/LKB1, UHRF2 and E4F1. Interacts with YWHAZ; the interaction enhances TP53 transcriptional activity.
Phosphorylation of YWHAZ on 'Ser-58' inhibits this interaction. Interacts (via DNA-binding domain) with MAML1 (via
N-terminus). Interacts with MKRN1. Interacts with PML (via C-terminus). Interacts with MDM2; leading to ubiquitination
and proteasomal degradation of TP53. Directly interacts with FBXO42; leading to ubiquitination and degradation of
TP53. Interacts (phosphorylated at Ser-15 by ATM) with the phosphatase PP2A-PPP2R5C holoenzyme; regulates
stress-induced TP53-dependent inhibition of cell proliferation. Interacts with PPP2R2A. Interacts with AURKA, DAXX,
BRD7 and TRIM24. Interacts (when monomethylated at Lys-382) with L3MBTL1. Isoform 1 interacts with isoform 2 and with
isoform 4. Interacts with GRK5. Binds to the CAK complex (CDK7, cyclin H and MAT1) in response to DNA damage.
Interacts with CDK5 in neurons. Interacts with AURKB, UHRF2 and NOC2L. Interacts (via N-terminus) with PTK2/FAK1; this
promotes ubiquitination by MDM2. Interacts with PTK2B/PYK2; this promotes ubiquitination by MDM2. Interacts with
PRKCG. Interacts with PPIF; the association implicates preferentially tetrameric TP53, is induced by oxidative stress
and is impaired by cyclosporin A (CsA). Interacts with human cytomegalovirus/HHV-5 protein UL123. Interacts with
SNAI1; the interaction induces SNAI1 degradation via MDM2-mediated ubiquitination and inhibits SNAI1-induced cell
invasion
Subcellular location: Cytoplasm. Nucleus. Nucleus, PML body. Endoplasmic reticulum. Mitochondrion matrix.
Note=Interaction with BANP promotes nuclear localization. Recruited into PML bodies together with CHEK2. Translocates
to mitochondria upon oxidative stress
Subcellular location: Isoform 1: Nucleus. Cytoplasm. Note=Predominantly nuclear but localizes to the cytoplasm when
expressed with isoform 4
Subcellular location: Isoform 2: Nucleus. Cytoplasm. Note=Localized mainly in the nucleus with minor staining in the
cytoplasm
Subcellular location: Isoform 3: Nucleus. Cytoplasm. Note=Localized in the nucleus in most cells but found in the
cytoplasm in some cells
Subcellular location: Isoform 4: Nucleus. Cytoplasm. Note=Predominantly nuclear but translocates to the cytoplasm
following cell stress
Subcellular location: Isoform 7: Nucleus. Cytoplasm. Note=Localized mainly in the nucleus with minor staining in the
cytoplasm
Subcellular location: Isoform 8: Nucleus. Cytoplasm. Note=Localized in both nucleus and cytoplasm in most cells. In
some cells, forms foci in the nucleus that are different from nucleoli
Subcellular location: Isoform 9: Cytoplasm
6/102 PDB 3D structures from and Proteopedia for TP53 (see all 102):
1A1U (3D)        1AIE (3D)        1C26 (3D)        1DT7 (3D)        1GZH (3D)        1H26 (3D)    
Secondary accessions: Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98
Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2
Q9UQ61
Alternative promoter usage, Alternative splicing: 9 isoforms:  P04637-1   P04637-2   P04637-3   P04637-4   P04637-5   P04637-6   P04637-7   P04637-8   
P04637-9   (Produced by alternative promoter usage and alternative splicing)

Explore the universe of human proteins at neXtProt for TP53: NX_P04637

Post-translational modifications:

  • Acetylated. Acetylation of Lys-382 by CREBBP enhances transcriptional activity. Deacetylation of Lys-382 by SIRT1
  • impairs its ability to induce proapoptotic program and modulate cell senescence1
  • Phosphorylation on Ser residues mediates transcriptional activation. Phosphorylated by HIPK1 (By similarity).
  • Phosphorylation at Ser-9 by HIPK4 increases repression activity on BIRC5 promoter. Phosphorylated on Thr-18 by VRK1.
    Phosphorylated on Ser-20 by CHEK2 in response to DNA damage, which prevents ubiquitination by MDM2. Phosphorylated on
    Ser-20 by PLK3 in response to reactive oxygen species (ROS), promoting p53/TP53-mediated apoptosis. Phosphorylated on
    Thr-55 by TAF1, which promotes MDM2-mediated degradation. Phosphorylated on Ser-33 by CDK7 in a CAK complex in
    response to DNA damage. Phosphorylated on Ser-46 by HIPK2 upon UV irradiation. Phosphorylation on Ser-46 is required
    for acetylation by CREBBP. Phosphorylated on Ser-392 following UV but not gamma irradiation. Phosphorylated on Ser-15
    upon ultraviolet irradiation; which is enhanced by interaction with BANP. Phosphorylated by NUAK1 at Ser-15 and
    Ser-392; was intially thought to be mediated by STK11/LKB1 but it was later shown that it is indirect and that
    STK11/LKB1-dependent phosphorylation is probably mediated by downstream NUAK1 (PubMed:21317932). It is unclear whether
    AMP directly mediates phosphorylation at Ser-15. Phosphorylated on Thr-18 by isoform 1 and isoform 2 of VRK2.
    Phosphorylation on Thr-18 by isoform 2 of VRK2 results in a reduction in ubiquitination by MDM2 and an increase in
    acetylation by EP300. Stabilized by CDK5-mediated phosphorylation in response to genotoxic and oxidative stresses at
    Ser-15, Ser-33 and Ser-46, leading to accumulation of p53/TP53, particularly in the nucleus, thus inducing the
    transactivation of p53/TP53 target genes. Phosphorylated by DYRK2 at Ser-46 in response to genotoxic stress.
    Phosphorylated at Ser-315 and Ser-392 by CDK2 in response to DNA-damage1
  • Dephosphorylated by PP2A-PPP2R5C holoenzyme at Thr-55. SV40 small T antigen inhibits the dephosphorylation by the AC
  • form of PP2A1
  • May be O-glycosylated in the C-terminal basic region. Studied in EB-1 cell line1
  • Ubiquitinated by MDM2 and SYVN1, which leads to proteasomal degradation. Ubiquitinated by RFWD3, which works in
  • cooperation with MDM2 and may catalyze the formation of short polyubiquitin chains on p53/TP53 that are not targeted
    to the proteasome. Ubiquitinated by MKRN1 at Lys-291 and Lys-292, which leads to proteasomal degradation.
    Deubiquitinated by USP10, leading to its stabilization. Ubiquitinated by TRIM24, which leads to proteasomal
    degradation. Ubiquitination by TOPORS induces degradation. Deubiquitination by USP7, leading to stabilization. Isoform
    4 is monoubiquitinated in an MDM2-independent manner1
  • Monomethylated at Lys-372 by SETD7, leading to stabilization and increased transcriptional activation. Monomethylated
  • at Lys-370 by SMYD2, leading to decreased DNA-binding activity and subsequent transcriptional regulation activity.
    Lys-372 monomethylation prevents interaction with SMYD2 and subsequent monomethylation at Lys-370. Dimethylated at
    Lys-373 by EHMT1 and EHMT2. Monomethylated at Lys-382 by SETD8, promoting interaction with L3MBTL1 and leading to
    repress transcriptional activity. Dimethylation at Lys-370 and Lys-382 diminishes p53 ubiquitination, through
    stabilizing association with the methyl reader PHF20. Demethylation of dimethylated Lys-370 by KDM1A prevents
    interaction with TP53BP1 and represses TP53-mediated transcriptional activation1
  • Sumoylated with SUMO11
  • View modification sites using PhosphoSitePlus2
  • View neXtProt modification sites for NX_P04637

  • TP53 Protein expression data from MOPED and PaxDb:    About this image 
    Estimated protein expression log10 (pmol).

    REFSEQ proteins (8 alternative transcripts): 
    NP_000537.3  NP_001119584.1  NP_001119585.1  NP_001119586.1  NP_001119587.1  NP_001119588.1  NP_001119589.1  NP_001119590.1  

    ENSEMBL proteins: 
     ENSP00000410739   ENSP00000352610   ENSP00000269305   ENSP00000398846   ENSP00000391127  
     ENSP00000391478   ENSP00000458393   ENSP00000425104   ENSP00000423862   ENSP00000424104  
     ENSP00000426252  
    Reactome Protein details: P04637
    Human Recombinant Protein Products: 
    EMD Millipore Purified and/or Recombinant TP53 Protein
    R&D Systems Recombinant & Natural Proteins for TP53 (p53)
    Enzo Life Sciences proteins for TP53
    OriGene Purified Proteins (see all 3): TP53
    OriGene Protein Over-expression Lysate (see all 4): TP53
    OriGene Custom Protein Services for TP53 
    GenScript Custom Purified and Recombinant Proteins Services for TP53
    Novus Biologicals TP53 Proteins
    Novus Biologicals TP53 Lysates
    Browse Sino Biological Recombinant Proteins
    ProSpec Recombinant Protein for TP53
    Uscn Proteins for TP53

    Gene Ontology (GO): 5/18 cellular component terms (GO ID links to tree view) (see all 18):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0000785chromatin IBA--
    GO:0000790nuclear chromatin IDA--
    GO:0005626insoluble fraction ----
    GO:0005634nucleus IDA18756595
    GO:0005654nucleoplasm TAS--


    TP53 for ontologies           About GeneDecksing



    TP53 Antibody Products: 
    EMD Millipore Mono- and Polyclonal Antibodies for the study of TP53
    R&D Systems Antibodies for TP53 (p53)
    Cell Signaling Technology (CST) Antibodies for TP53  (p53)
    OriGene Antibodies (see all 21): TP53
    OriGene Custom Antibody Services for TP53 
    GenScript Superior Antibodies for TP53
    Novus Biologicals TP53 Antibodies
    Abcam antibodies for TP53 
    Uscn Antibodies for TP53
    ThermoFisher Antibody for TP53

    Assay Products for TP53: 
    EMD Millipore Kits and Assays for the Analysis of TP53
    OriGene Custom Immunoassay Development
    Browse OriGene Fluorogenic Cell Assay Kits
    R&D Systems ELISAs for TP53 (p53)         (see all)
    GenScript Custom Assay Services for TP53
    Cell Signaling Technology (CST) Sandwich ELISA Kits for TP53 (p53)
    Enzo Life Sciences assays for TP53
    Uscn ELISAs and CLIAs for TP53


    (According to InterPro, ProtoNet, UniProtKB, and/or BLOCKS, Sets of similar genes according to GeneDecks)
    About This Section

    TP53 for domains           About GeneDecksing

    5/6 InterPro domains/families (see all 6):
     IPR011615 p53_DNA-bd
     IPR012346 p53/RUNT-type_TF_DNA-bd
     IPR002117 p53_tumour_suppressor
     IPR008967 p53-like_TF_DNA-bd
     IPR013872 p53_transactivation_domain

    Graphical View of Domain Structure for InterPro Entry P04637

    ProtoNet protein and cluster: P04637

    1 Blocks protein family: IPB010991 p53

    UniProtKB/Swiss-Prot: P53_HUMAN, P04637
    Domain: The nuclear export signal acts as a transcriptional repression domain. The TADI and TADII motifs (residues 17
    to 25 and 48 to 56) correspond both to 9aaTAD motifs which are transactivation domains present in a large number of
    yeast and animal transcription factors
    Similarity: Belongs to the p53 family


    (According to 1UniProtKB, Genatlas, LifeMap Discovery™, IUBMB, and/or 2DME, Human phenotypes from GenomeRNAi, Animal models from MGI Mar 06 2013,
    bound targets from SABiosciences, miRNA Gene Targets from miRTarBase shRNA from OriGene, RNAi from EMD Millipore, siRNAs from OriGene, QIAGEN, microRNA from QIAGEN, Gene Editing from DNA2.0, Clones from EMD Millipore, OriGene, SwitchGear Genomics, GenScript, Sino Biological, DNA2.0, and Vector BioLabs, Cell Lines from GenScript, LifeMap BioReagents, In Situ Hybridization Assays from Advanced Cell Diagnostics, Ontologies according to Gene Ontology Consortium 01 Mar 2013 via Entrez Gene.)
    About This Section

    Function Summary:

         UniProtKB/Swiss-Prot: P53_HUMAN, P04637
    Function: Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the
    physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to
    negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes
    is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and
    FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF is involved in
    activating oxidative stress-induced necrosis; te function is largely independent of transcription. Induces the
    transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in
    TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation.
    Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to
    DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from
    some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth
    suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis
    Induction: Up-regulated in response to DNA damage. Isoform 2 is not induced in tumor cells in response to stress

         Genatlas biochemistry entry for TP53:
    tumor suppressor protein p53 required for G1 growth arrest by WAF1 (CDKN1A),following DNA damage or induction of
    apoptosis,also regulating a G2 checkpoint through cyclin B1,transcriptional activator through acetylation of
    transactivation site by CREBBP binding MDM2 resulting in transcriptional silencing and ubiquitin/proteasome dependent
    degradation of p53,activated by conjugation to UBL1 (SUMO1),putative up-regulated c-MYC target gene,putative
    teratologic suppressor gene and modulator of TFIIH (GTF2H),associated in nucleotide excision repair,activated by ATM
    in association with 14.3.3 proteins (YWHA*),tumor suppressor gene (see TSG17A),mutated in cancers such as pancreas and
    endometrial carcinomas,in Barrett's adenocarcinoma (and esophageal squamous cell carcinoma),in hepatocellular
    carcinoma with poor prognosis

    10/1931 SABiosciences Target genes for TP53 (see all 1931):
    AATF ABCC3 ABCC6P2 ABCD1 ABCF1 ABHD12 ABHD15 ABHD4 ABHD8 ABTB2

    miRNA
    Products:
        
    miRTarBase miRNAs that target TP53:
    hsa-mir-1285 (MIRT005474), hsa-mir-16 (MIRT005764), hsa-mir-125a-5p (MIRT004071), hsa-mir-25 (MIRT005417), hsa-mir-221 (MIRT005785), hsa-mir-15a (MIRT005763), hsa-mir-612 (MIRT005476), hsa-mir-222 (MIRT005786), hsa-mir-125b (MIRT000535), hsa-mir-30d (MIRT005418)

    OriGene 3'-UTR Clone (see all 7): TP53
    Browse MicroRNA Expression Plasmids
    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat TP53
    8/17 QIAGEN miScript miRNA Assays for microRNAs that regulate TP53 (see all 17):
    hsa-miR-576-3p hsa-let-7d hsa-miR-202 hsa-let-7c hsa-let-7g hsa-let-7a hsa-miR-98 hsa-miR-22
    SwitchGear 3'UTR luciferase reporter plasmidTP53 3' UTR sequence
    Inhib. RNA
    Products:
        
    Browse for Gene Knock-down Tools from EMD Millipore
    OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for TP53 (see all 4)
    OriGene shRNA RFP: TP53
    OriGene siRNA: TP53
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat TP53

    Gene Editing
    Products:
    DNA2.0 Custom Protein Engineering Service for TP53

    Clone
    Products:
         
    Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
    OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for TP53 (see all 9)
    OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for TP53 (see all 7)
    OriGene custom cloning services – gene synthesis, subcloning, mutagenesis, variant library, vector shuttling 
    GenScript: all cDNA clones in your preferred vector (see all 7): TP53 (NM_000546)
    Sino Biological Human cDNA Clone for TP53
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for TP53
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat TP53 

    Cell Line
    Products:
         
    GenScript Custom overexpressing Cell Line Services for TP53
    Search LifeMap BioReagents cell lines for TP53

    In Situ Assay
    Products:
       

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for TP53

    Gene Ontology (GO): 5/30 molecular function terms (GO ID links to tree view) (see all 30):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0000739DNA strand annealing activity ----
    GO:0001077RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription IEA--
    GO:0001085RNA polymerase II transcription factor binding IPI18549481
    GO:0001228RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription IDA17146433
    GO:0002020protease binding IPI11923872


    TP53 for ontologies           About GeneDecksing


    4 GenomeRNAi human phenotypes for TP53:
     Decreased viability of wild-ty  Enable proliferation in B-Raf   Increased cell death HMECs cel  Increased resistance to MDM2 i 

    Animal Models:
         Mouse knock-outs for TP53: Trp53tm1Mlh Trp53tm3Wahl Trp53tm5Wahl Trp53tm2Wahl Trp53tm1Tyj Trp53tm1Mok
                                                   Trp53tm1.1Brn Trp53tm1Brd Trp53tm1Sia
         15/27 MGI mutant phenotypes (inferred from 64 alleles(MGI details for Trp53) (see all 27):
     adipose tissue  behavior/neurological  cardiovascular system  cellular  craniofacial 
     digestive/alimentary  embryogenesis  endocrine/exocrine gland  growth/size  hematopoietic system 
     homeostasis/metabolism  immune system  integument  limbs/digits/tail  liver/biliary system 

    TP53 for phenotypes           About GeneDecksing


    (Pathways according to EMD Millipore, R&D Systems, Cell Signaling Technology, KEGG, PharmGKB, BioSystems, Reactome, Tocris Bioscience, GeneGo (Thomson Reuters), QIAGEN, and/or UniProtKB, Sets of similar genes according to GeneDecks, Interaction Networks according to SABiosciences, and/or STRING, Interactions according to 1UniProtKB, 2MINT, 3I2D, and/or 4STRING, with links to IntAct and Ensembl, Ontologies according to Gene Ontology Consortium 01 Mar 2013 via Entrez Gene).
    About This Section

    Unified GeneCards pathways - 5/91 super-pathways (see all 91About this table 
    See pathways by source

    Super-pathwaycontained gene-specific pathways
    1Ubiquitinated Orc1 is degraded by the proteasome
    Autodegradation of the E3 ubiquitin ligase COP10.92
    p53-Dependent G1 DNA Damage Response0.83
    Stabilization of p530.91
    G1/S DNA Damage Checkpoints0.79
    p53-Dependent G1/S DNA damage checkpoint0.83
    Cell Cycle Checkpoints0.42
    2Apoptotic Pathways in Synovial Fibroblasts
    Apoptotic Pathways in Synovial Fibroblasts1.00
    Telomerase Components in Cell Signaling0.72
    p53 Mediated Apoptosis0.84
    Cellular Apoptosis Pathway0.65
    Mitochondrial Apoptosis0.73
    3Glioma
    Glioma1.00
    Prostate cancer0.39
    Non-small cell lung cancer0.53
    Signaling Pathways in Glioblastoma0.36
    Melanoma0.43
    4Development HGF signaling pathway
    Development_Neurotrophin family signaling0.45
    Apoptosis and survival Role of CDK5 in neuronal death and survival0.24
    Development Neurotrophin family signaling0.45
    Neurotrophin signaling pathway0.20
    Apoptosis and survival_Role of CDK5 in neuronal death and survival0.24
    5Endometrial cancer
    Endometrial cancer1.00
    Signal transduction PTEN pathway0.45
    Signal transduction_PTEN pathway0.45
    Colorectal cancer0.42

    Pathway sources
    See GeneCards unified pathways
    Show all pathways

    5/16 EMD Millipore Pathways for TP53 (see all 16)
        DNA damage ATM/ATR regulation of G1/S checkpoint
    Proteolysis Putative SUMO-1 pathway
    Immune response MIF in innate immunity response
    DNA damage DNA-damage-induced responses
    DNA damage Role of SUMO in p53 regulation

    1 R&D Systems Pathway for TP53
        Apoptosis Signaling Pathways

    5/41 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for TP53 (see all 41)
        Telomerase Components in Cell Signaling
    UVB-Induced MAPK Signaling
    Mitochondrial Apoptosis
    Molecular Mechanisms of Cancer
    TRKA Signaling

    2 Cell Signaling Technology (CST) Pathways for TP53
        Cell Cycle / Checkpoint Control
    DNA Damage

    4 Tocris Bioscience Pathways for TP53
        Akt Pathway
    Apoptosis Pathway
    MAPK Pathway
    mTOR Pathway

    5/13 GeneGo (Thomson Reuters) Pathways for TP53 (see all 13)
        DNA damage ATM/ATR regulation of G1/S checkpoint
    Immune response MIF in innate immunity response
    Transcription P53 signaling pathway
    Development Neurotrophin family signaling
    Signal transduction AKT signaling

    5/34 BioSystems Pathways for TP53 (see all 34
        Signaling Pathways in Glioblastoma
    Fluoropyrimidine Activity
    Cell cycle
    Senescence and Autophagy
    AMPK signaling

    5/9        Reactome Pathways for TP53 (see all 9)
        Hemostasis
    Stabilization of p53
    Cell Cycle
    G1/S DNA Damage Checkpoints
    p53-Dependent G1 DNA Damage Response

    2 PharmGKB Pathways for TP53
        Doxorubicin Pathway (Cancer Cell), Pharmacodynamics
    Fluoropyrimidine Pathway, Pharmacodynamics

    5/23         Kegg Pathways  (Kegg details for TP53) (see all 23):
        MAPK signaling pathway
    Cell cycle
    p53 signaling pathway
    Apoptosis
    Wnt signaling pathway


    TP53 for pathways           About GeneDecksing

    Interactions:

        SABiosciences Gene Network CentralTM Interacting Genes and Proteins Network for TP53

    STRING Interaction Network Preview (showing 5 interactants - click image to see 25)

    5/885 Interacting proteins for TP53 (P046371, 2, 3 ENSP000002693054) via UniProtKB, MINT, STRING, and/or I2D (see all 885)
    InteractantInteraction Details
    GeneCardExternal ID(s)
    MDM2Q009871, 2, 3, ENSP000004172814EBI-366083,EBI-389668 MINT-6540920 MINT-4793511 MINT-6823775 MINT-7013943 MINT-8303857 MINT-6540905 MINT-68742 MINT-8385459 MINT-56681 MINT-8374464 MINT-58468 MINT-7013791 MINT-68743 MINT-7013956 MINT-4545014 MINT-8339574 MINT-4049631 MINT-6540776 MINT-6801380 MINT-8374452 MINT-58465 MINT-7013688 MINT-7013802 MINT-4303990 MINT-8339590 MINT-6665330 MINT-4793467 MINT-8380636 MINT-4049616 MINT-4054304 MINT-7905142 MINT-8385480 MINT-7013780 MINT-6540889 MINT-8385531 MINT-8385552 MINT-8385886 MINT-8388795 MINT-8415355 MINT-6540807 MINT-8391984 MINT-7905326 MINT-6540796 I2D: score=12 STRING: ENSP00000417281
    HNRNPUL1Q9BUJ21, 2, 3, ENSP000003758634EBI-366083,EBI-2339292 MINT-58678 MINT-58677 MINT-58673 MINT-58674 MINT-58676 MINT-58675 MINT-8415355 MINT-58672 I2D: score=3 STRING: ENSP00000375863
    UBCP0CG482, 3, ENSP000003448184MINT-7220023 MINT-4051326 MINT-4304004 MINT-4054804 MINT-4304143 MINT-6801380 MINT-6615153 MINT-6541035 MINT-7299234 MINT-7298704 MINT-6799774 MINT-7013815 MINT-4052207 MINT-7219995 MINT-5114741 I2D: score=5 STRING: ENSP00000344818
    EP300Q094721, 2, 3, ENSP000002632534EBI-366083,EBI-3908041 MINT-69507 MINT-8152513 MINT-8152530 MINT-8392126 MINT-2830826 MINT-7263630 MINT-6628507 MINT-8152544 I2D: score=7 STRING: ENSP00000263253
    PSME3P612892, 3, ENSP000002933624MINT-6540807 MINT-6540940 MINT-6540866 MINT-6540920 MINT-6540876 MINT-6540776 MINT-6541016 MINT-6540960 MINT-6540796 I2D: score=3 STRING: ENSP00000293362
    About this table

    Gene Ontology (GO): 5/92 biological process terms (GO ID links to tree view) (see all 92):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0000060protein import into nucleus, translocation IEA--
    GO:0000075cell cycle checkpoint TAS--
    GO:0000122negative regulation of transcription from RNA polymerase II promoter ISS19749791
    GO:0000733DNA strand renaturation IDA8183576
    GO:0001701in utero embryonic development IEA--


    TP53 for ontologies           About GeneDecksing



    (Chemical Compounds according to UniProtKB, Enzo Life Sciences, EMD Millipore, Tocris Bioscience HMDB, BitterDB, and/or Novoseek, and Drugs according to DrugBank, Enzo Life Sciences, and/or PharmGKB, with drugs/clinical trials/news search links to CenterWatch)
    About This Section

    TP53 for compounds           About GeneDecksing

    EMD Millipore small molecules for TP53:
    Small Molecule - inhibitor
    Enzo Life Sciences drugs & compounds for TP53

    Compounds for TP53 available from Tocris Bioscience    About this table
    CompoundAction CAS #
    CP 31398 dihydrochloridep53-stabilizing agent[259199-65-0]
    Pifithrin-alpha hydrobromidep53 inhibitor. Also aryl hydrocarbon receptor agonist[63208-82-2]
    MIRA-1Restores mutant p53 activity; proapoptotic[72835-26-8]
    RITAp53-MDM2 interaction inhibitor; antitumor[213261-59-7]
    RETRA hydrochlorideAntitumor agent; suppresses mutant p53-bearing cancer cells[1036069-26-7]

    1 DrugBank Compound for TP53    About this table
    CompoundSynonyms CAS #TypeActionsPubMed Ids
    1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine-- --target--10592235

    10/117 Novoseek chemical compound relationships for TP53 gene (see all 117)    About this table
    Compound   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    paraffin 76.9 382 8640471 (4), 7726729 (4), 8434637 (4), 15363320 (4) (see all 99)
    cisplatin 74 1151 12492119 (9), 9811465 (8), 18064040 (7), 14513366 (7) (see all 99)
    noxa 72.7 89 17216584 (4), 17653088 (3), 20160496 (3), 15598651 (3) (see all 52)
    hpvs 71.4 72 20200430 (2), 11002226 (2), 8726818 (2), 9714244 (1) (see all 50)
    estrogen 71 898 14595509 (6), 9744308 (5), 10719737 (4), 15312749 (4) (see all 99)
    progesterone 69.1 712 12416559 (6), 14595509 (5), 9635673 (5), 9744308 (5) (see all 99)
    doxorubicin 67.6 464 15116093 (6), 18263706 (6), 8988061 (5), 11745235 (5) (see all 99)
    aflatoxin b1 63.4 212 16280384 (6), 8921985 (5), 19524575 (5), 1310637 (5) (see all 90)
    5fluorouracil 63.2 456 17634554 (12), 11044365 (7), 14703431 (7), 19810096 (6) (see all 99)
    camptothecin 63.1 172 10536167 (6), 9815856 (5), 19445707 (4), 17709397 (3) (see all 75)

    5 PharmGKB related drug/compound annotations for TP53 gene
    Drug/compound PharmGKB Annotation
    antineoplastic agentsCA  
    cisplatinCA  
    cyclophosphamideCA  
    fluorouracilCA  
    paclitaxelCA  
    About this table

    Search CenterWatch for drugs/clinical trials and news about TP53 / P53 

    (Secondary structures according to fRNAdb,
    GenBank/EMBL/DDBJ Accessions according to
    Unigene (Build 235 Homo sapiens; Mar 10 2013) or GenBank,
    RefSeq according to Entrez Gene,
    DOTS (version 10), and/or AceView, transcript ids from Ensembl with links to UCSC,
    exon structure from GeneLoc, alternative splicing isoforms according to ASD and/or ECgene,
    RNAi Products from EMD Millipore,
    siRNAs from OriGene, QIAGEN, shRNA from OriGene, microRNA from QIAGEN,
    Tagged/untagged cDNA clones from OriGene, SwitchGear Genomics, GenScript, DNA2.0, Vector BioLabs, Primers from OriGene, SABiosciences, and/or QIAGEN )
    About This Section

    REFSEQ mRNAs for TP53 gene (8 alternative transcripts): 
    NM_000546.5  NM_001126112.2  NM_001126113.2  NM_001126114.2  NM_001126115.1  NM_001126116.1  NM_001126117.1  NM_001126118.1  

    Unigene Clusters for TP53:

    Tumor protein p53
    Hs.437460  [show with all ESTs], Hs.740601  [show with all ESTs]
    Unigene Representative Sequences: NM_001126114, BM469215
    16 Ensembl transcripts including schematic representations, and UCSC links where relevant:
    ENST00000413465(uc002gig.1) ENST00000359597(uc002gih.3) ENST00000504290(uc010cnf.1)
    ENST00000510385(uc010cng.1) ENST00000504937(uc010cne.1 uc002gii.1)
    ENST00000269305(uc002gim.2 uc002gij.2 uc002gin.2 uc002gio.2 uc010cnk.1)
    ENST00000455263(uc010cnh.1) ENST00000420246(uc010cni.1) ENST00000445888
    ENST00000576024 ENST00000509690(uc010cnj.1) ENST00000514944 ENST00000574684
    ENST00000505014(uc010vug.2) ENST00000508793 ENST00000503591

    miRNA
    Products:
         
    OriGene 3'-UTR Clone (see all 7): TP53
    Browse OriGene MicroRNA Expression Plasmids
    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat TP53
    8/17 QIAGEN miScript miRNA Assays for microRNAs that regulate TP53 (see all 17):
    hsa-miR-576-3p hsa-let-7d hsa-miR-202 hsa-let-7c hsa-let-7g hsa-let-7a hsa-miR-98 hsa-miR-22
    SwitchGear 3'UTR luciferase reporter plasmidTP53 3' UTR sequence
    Inhib. RNA
    Products:
         
    Browse for Gene Knock-down Tools from EMD Millipore
    OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for TP53 (see all 4)
    OriGene shRNA RFP: TP53
    OriGene siRNA: TP53
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat TP53
    Clone
    Products:
         
    OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for TP53 (see all 9)
    OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for TP53 (see all 7)
    OriGene custom cloning services – gene synthesis, subcloning, mutagenesis, variant library, vector shuttling 
    GenScript: all cDNA clones in your preferred vector (see all 7): TP53 (NM_000546)
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for TP53
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat TP53 
    Primer
    Products:
        
    OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for TP53
    Browse OriGene validated miRNA SYBR primer pairs
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat TP53
      QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat TP53
      Search QIAGEN QuantiFast Probe-based Assays in human, mouse, rat TP53

    Additional cDNA sequence: 

    AY627884.1 DQ648883.1 

    17 DOTS entries:

    DT.92469229  DT.100788714  DT.120961435  DT.100788713  DT.75152217  DT.40283865  DT.95274968  DT.100712946 
    DT.120961349  DT.100788719  DT.40120491  DT.120961395  DT.100788715  DT.92010563  DT.120961350  DT.120961391 
    DT.120961408 

    24/112 AceView cDNA sequences (see all 112):

    BQ066009 S66666 AA291539 BU174921 AA379547 X60016 CK904490 AA358870 
    X02469 BU673953 X60018 CR624912 CA432254 BQ057682 BX952582 X60012 
    AY627884 BE886147 AW865736 AI539544 CR608294 AA662570 BQ923115 X60017 

    GeneLoc Exon Structure

    5/9 Alternative Splicing Database (ASD) splice patterns (SP) for TP53 (see all 9)    About this scheme

    ExUns: 1a · 1b ^ 2 ^ 3 ^ 4 ^ 5a · 5b ^ 6 ^ 7 ^ 8 ^ 9a · 9b ^ 10a · 10b ^ 11 ^ 12a · 12b · 12c
    SP1:                                -                             -           -     -                           
    SP2:                                                              -                                             
    SP3:                                                              -           -                                 
    SP4:                                                              -           -     -                           
    SP5:                                                                          -     -                           


    ECgene alternative splicing isoforms for TP53

    (RNA expression data according to H-InvDB, NONCODE, miRBase, and RNAdb, Expression images according to data from BioGPS, Illumina Human BodyMap, and CGAP SAGE, Sets of similar genes according to GeneDecks, in vivo and in vitro expression data from LifeMap Discovery™, plus additional links to Genevestigator, and/or SOURCE, and/or BioGPS, and/or UniProtKB,
    PCR Arrays from SABiosciences, Primers from OriGene, SABiosciences, and/or QIAGEN, In Situ Hybridization Assays from Advanced Cell Diagnostics)
    About This Section

    TP53 expression in normal human tissues (normalized intensities)
    See probesets specificity/sensitivity at GeneAnnot
    About this imageBioGPS
    CGAP TAG: GAGGAGCCGC

    Microarray
    RNAseq (Illumina Body Map)
    (100×FPKM)½
    SAGE (Serial Analysis of Gene Expression)

    About this image

    TP53 expression in embryonic tissues and stem cells
    Expression by the Database of Embryonic development, Stem cell research, and Regenerative medicine    About this table
    1 LifeMap In Vivo Development Anatomical Compartment/Cell 
    Tissue Anatomical Compartment CellCategory (developmental path)
    Neural CrestCranial Neural CrestCranial Neural Crest CellsNeural Crest
    Expression: Positive    Negative     Selective marker
    Experimental details: Curated     Microarrays     In-situ hybridization
    Stem Cell Differentiation: 1 LifeMap Cell 
    NameCategory
    Induced pluripotent stem cell line 20D17 (Induced Pluripotent Stem Cell)Early Embryo, Fibroblast

    See TP53 Protein Expression from SPIRE MOPED and PaxDB
    Genevestigator expression for TP53

    SOURCE GeneReport for Unigene clusters: Hs.437460 Hs.740601

    UniProtKB/Swiss-Prot: P53_HUMAN, P04637
    Tissue specificity: Ubiquitous. Isoforms are expressed in a wide range of normal tissues but in a tissue-dependent
    manner. Isoform 2 is expressed in most normal tissues but is not detected in brain, lung, prostate, muscle, fetal
    brain, spinal cord and fetal liver. Isoform 3 is expressed in most normal tissues but is not detected in lung, spleen,
    testis, fetal brain, spinal cord and fetal liver. Isoform 7 is expressed in most normal tissues but is not detected in
    prostate, uterus, skeletal muscle and breast. Isoform 8 is detected only in colon, bone marrow, testis, fetal brain
    and intestine. Isoform 9 is expressed in most normal tissues but is not detected in brain, heart, lung, fetal liver,
    salivary gland, breast or intestine

        SABiosciences Expression via Pathway-Focused PCR Arrays including TP53 (see all 37): 
              Lung Cancer in human mouse rat
              Lymphoma in human mouse rat
              Prostate Cancer in human mouse rat
              Hypoxia Signaling Pathway in human mouse rat
              Stress & Toxicity PathwayFinder in human mouse rat

    Primer
    Products:
    OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for TP53
    Browse OriGene validated miRNA SYBR primer pairs
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat TP53
    QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat TP53
    Search QIAGEN QuantiFast Probe-based Assays in human, mouse, rat TP53
    In Situ
    Assay Products:
     

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for TP53

    (Orthologs according to 1,2HomoloGene (2older version, for species not in 1newer version), 3euGenes, 4SGD , 5MGI Mar 06 2013, with possible further links to Flybase and/or WormBase, and/or 6Ensembl pan taxonomic compara , Gene Trees according to Ensembl and TreeFam)
    About This Section

    This gene was present in the common ancestor of animals.

    Orthologs for TP53 gene from 3/17 species (see all 17)    About this table
    Organism Taxonomic
    classification
    Gene Description Human
    Similarity
    Orthology
    Type
    Details
    African clawed frog
    (Xenopus laevis)
    Amphibia Xl.209432 Xenopus laevis transcribed sequence with weak similarity more 78.01(n)    BU152764.1 
    zebrafish
    (Danio rerio)
    Actinopterygii tp532 tumor protein p53 74.13(n)   30590  AF365873.1 
    fruit fly
    (Drosophila melanogaster)
    Insecta p536
    p53
    13(a)
    possible ortholog
    3R(18875379-18879804)


    ENSEMBL Gene Tree for TP53 (if available)
    TreeFam Gene Tree for TP53 (if available) 

    (Paralogs according to 1HomoloGene,
    2Ensembl, and 3SIMAP, Pseudogenes according to 4Pseudogene.org Build 68)
    About This Section
    Paralogs for TP53 gene
    TP732  TP632  
    3 SIMAP similar genes for TP53 using alignment to 88 protein entries:     P53_HUMAN (see all proteins):
    p53    TP73    TP63

    TP53 for paralogs           About GeneDecksing



    (SNPs/Variants according to the 1NCBI SNP Database, 2Ensembl, 3PupaSUITE, UniProtKB, and DNA2.0, Linkage Disequilibrium by HapMap, Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene Mutation Database (HGMD) and the Locus Specific Mutation Databases (LSDB), Blood group antigen gene mutations by BGMUT, Resequencing Primers from QIAGEN, Cancer Mutation PCR Arrays and Assays and Copy Number PCR Arrays from SABiosciences)
    About This Section

    10/603 NCBI SNPs in TP53 are shown (see all 603    About this table
    Genomic DataTranscription Related DataAllele Frequencies
    SNP IDValidClinical
    significance
    Chr 17 posSequence#AA
    Chg
    TypeMore#Allele
    freq
    PopTotal
    sample
    More
    ----------
    rs10425221,2
    C,F,A,H,non-pathogenic7579472(-) TCCCCG/CCGTGG 13 /P /R us2k1 mis135Minor allele frequency- C:0.40MN NS EA NA WA EU 7378
    rs1219126671,2
    Cpathogenic7577084(-) CACAGA/TGGAAG 16 E V mis10--------
    rs289345741,2
    Cpathogenic7577094(-) GAGACC/TGGCGC 16 R W mis1 ese32Minor allele frequency- T:0.00NA 4
    rs289345761,2
    C,pathogenic7577120(-) GGTGCG/ATGTTT 16 /H /R mis1 ese32Minor allele frequency- A:0.00NA 4
    rs289345771,2
    Cpathogenic7577511(-) CACACT/AGGAAG 16 /Q /L mis1 ese32Minor allele frequency- A:0.00NA 4
    rs115406521,2
    Cpathogenic7577538(-) GAACCG/AGAGGC 16 /Q /R mis1 ese36Minor allele frequency- A:0.00NS EA NA 406
    rs1219126511,2
    Cpathogenic7577539(-) TGAACC/TGGAGG 16 R W mis10--------
    rs289345731,2
    Cpathogenic7577559(-) CAGTTC/TCTGCA 16 S F mis1 ese32Minor allele frequency- T:0.00NA 4
    rs289345781,2
    Cpathogenic7578406(-) GAGGCG/ACTGCC 16 /H /R mis12Minor allele frequency- A:0.00NA 4
    rs289348731,2
    Cpathogenic7578532(-) CAAGAT/CGTTTT 16 /T /M mis11Minor allele frequency- C:0.00NA 2

    HapMap Linkage Disequilibrium report for TP53 (7565097 - 7590863 bp)
    Structural Variations (Copy Number Variations, Insertions/Deletions, Inversions)
          Database of Genomic Variants (DGV) variations for TP53: --
    Human Gene Mutation Database (HGMD): TP53

    Locus Specific Mutation Databases (LSDB): TP53

    5/120 SABiosciences Cancer Mutation PCR Assays for TP53 (see all 120):
    Cosmic IdAA Change
    10812p.S241F
    10856p.E294*
    11089p.I195T
    10889p.H179R
    43559p.V173L
    5/22 SABiosciences Cancer Mutation PCR Arrays containing TP53 (see all 22):
    Breast Cancer
    Cancer Comprehensive Panel 384HT
    Lung Cancer
    Myelodysplastic Syndromes
    Soft Tissue Tumors
    2 SABiosciences qBiomarker Copy Number PCR Arrays containing TP53:
    Oncogenes & Tumor Suppressor Genes 384HC
    WNT Signaling
    QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing TP53
    DNA2.0 Custom Variant and Variant Library Synthesis for TP53

    (in which this Gene is Involved, According to MalaCards, OMIM, UniProtKB, the University of Copenhagen DISEASES database, Novoseek, Genatlas, GeneTests, GAD, HuGE Navigator, and/or TGDB.)
    About This Section

    TP53 for disorders           About GeneDecksing

    OMIM gene information: 191170   
    OMIM disorders: 114500  151623  114550  259500  260500  607107  260350  202300  114480  
    UniProtKB/Swiss-Prot: P53_HUMAN, P04637
  • Note=TP53 is found in increased amounts in a wide variety of transformed cells. TP53 is frequently mutated or
  • inactivated in about 60% of cancers. TP53 defects are found in Barrett metaplasia a condition in which the normally
    stratified squamous epithelium of the lower esophagus is replaced by a metaplastic columnar epithelium. The condition
    develops as a complication in approximately 10% of patients with chronic gastroesophageal reflux disease and
    predisposes to the development of esophageal adenocarcinoma
  • Defects in TP53 are a cause of esophageal cancer (ESCR) [MIM:133239]
  • Defects in TP53 are a cause of Li-Fraumeni syndrome (LFS) [MIM:151623]. LFS is an autosomal dominant familial
  • cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45
    years with a first degree relative affected by any tumor before 45 years and another first degree relative with any
    tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819
    and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse
    set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53
    germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and
    adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15,
    rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers
  • Defects in TP53 are involved in head and neck squamous cell carcinomas (HNSCC) [MIM:275355]; also known as
  • squamous cell carcinoma of the head and neck
  • Defects in TP53 are a cause of lung cancer (LNCR) [MIM:211980]. LNCR is a common malignancy affecting tissues
  • of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3
    major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often
    diagnosed at an advanced stage and has a poor prognosis
  • Defects in TP53 are a cause of choroid plexus papilloma (CPLPA) [MIM:260500]. Choroid plexus papilloma is a
  • slow-growing benign tumor of the choroid plexus that often invades the leptomeninges. In children it is usually in a
    lateral ventricle but in adults it is more often in the fourth ventricle. Hydrocephalus is common, either from
    obstruction or from tumor secretion of cerebrospinal fluid. If it undergoes malignant transformation it is called a
    choroid plexus carcinoma. Primary choroid plexus tumors are rare and usually occur in early childhood
  • Defects in TP53 are a cause of adrenocortical carcinoma (ADCC) [MIM:202300]. ADCC is a rare childhood tumor of
  • the adrenal cortex. It occurs with increased frequency in patients with the Beckwith-Wiedemann syndrome and is a
    component tumor in Li-Fraumeni syndrome
  • Defects in TP53 are the cause of susceptibility to basal cell carcinoma 7 (BCC7) [MIM:614740]. A common
  • malignant skin neoplasm that typically appears on hair-bearing skin, most commonly on sun-exposed areas. It is slow
    growing and rarely metastasizes, but has potentialities for local invasion and destruction. It usually develops as a
    flat, firm, pale area that is small, raised, pink or red, translucent, shiny, and waxy, and the area may bleed
    following minor injury. Tumor size can vary from a few millimeters to several centimeters in diameter

    20/594 diseases for TP53 (see all 594):    About MalaCards
    li-fraumeni syndrome    li-fraumeni-like syndrome    open-angle glaucoma    brooke-spiegler syndrome
    recessive dystrophic epidermolysis bullosa    sturge-weber syndrome    mutyh-associated polyposis    von hippel-lindau disease
    marginal zone b-cell lymphoma    adult astrocytic tumour    xeroderma pigmentosum    estrogen-receptor positive breast cancer
    squamous cell carcinoma    atypical teratoid rhabdoid tumor    xeroderma pigmentosum, group a    primitive neuroectodermal tumor
    adult-onset still's disease    malignant peripheral nerve sheath tumor    lymphoepithelioma-like carcinoma    alveolar soft part sarcoma

    20/55 diseases from the University of Copenhagen DISEASES database for TP53 (see all 55):
    Carcinoma     Breast cancer     Li-Fraumeni syndrome     Lung cancer
    Retinoblastoma     Colorectal cancer     Malignant glioma     Urinary bladder cancer
    Ovarian cancer     Adenoma     Leukemia     Hepatocellular carcinoma
    Cervical cancer     Lymphoma     Skin cancer     Esophageal cancer
    Endometrial cancer     Melanoma     Prostate cancer     Pancreatic cancer

    96 Novoseek disease relationships for TP53 gene (see top 10)    About this table

    Disease   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    tumors 93.8 24003 8777377 (10), 7901994 (9), 8007011 (9), 8324748 (8) (see all 99)
    li-fraumeni syndrome 90.7 344 1373881 (5), 17483435 (3), 10980596 (3), 10484981 (3) (see all 99)
    cancer 90.2 7050 17598983 (10), 18223686 (8), 15055300 (7), 12561442 (7) (see all 99)
    carcinoma 87.5 3357 9110348 (10), 8062281 (9), 16033093 (8), 7927312 (8) (see all 99)
    carcinoma squamous cell 86.8 1909 9127380 (8), 8826924 (7), 10445528 (6), 11255264 (6) (see all 99)
    retinoblastoma 85.1 701 10792093 (8), 9337350 (6), 11306502 (5), 8224613 (5) (see all 99)
    microsatellite instability 85 363 9731891 (6), 9716224 (5), 11290569 (5), 12612901 (5) (see all 99)
    allelic loss 83.7 407 16293976 (5), 7909153 (5), 8467510 (4), 11520271 (4) (see all 99)
    adenocarcinoma 82.7 1551 12823203 (7), 17982662 (7), 9379505 (6), 10674608 (6) (see all 99)
    breast cancer 81.9 2818 7917542 (8), 8679460 (8), 12170762 (7), 15566648 (6) (see all 99)
    metastasis 79.5 1670 10072877 (7), 10357418 (6), 10416688 (6), 10645403 (6) (see all 99)
    breast carcinoma 79.4 600 12743423 (5), 9216675 (5), 16007576 (5), 7493140 (4) (see all 99)
    ataxia telangiectasia 78.1 181 8247533 (4), 9467855 (3), 8500101 (2), 10563391 (2) (see all 99)
    glioblastoma 78.1 695 9839169 (8), 10328545 (7), 11511795 (7), 14961077 (6) (see all 99)
    colorectal cancer 78 1153 9587516 (8), 10601600 (7), 10695624 (6), 16604493 (6) (see all 99)
    colorectal carcinoma 77.5 542 1520594 (5), 17592558 (5), 1546693 (4), 10910245 (4) (see all 99)
    nsclc 76.8 1082 9416838 (6), 8664051 (6), 9627113 (6), 20491334 (6) (see all 99)
    dysplasia 76.8 1027 11815980 (7), 15228225 (6), 9306559 (6), 10993651 (6) (see all 99)
    cancer lung 76.4 1501 9918210 (7), 15312402 (7), 18363031 (6), 10418172 (6) (see all 99)
    primary tumor 76.1 588 8606380 (7), 18688630 (6), 8969671 (6), 18836853 (5) (see all 99)
    bladder cancer 75.6 784 1540947 (9), 11690548 (7), 8731915 (6), 12629332 (6) (see all 99)
    colon cancer 75 581 11914640 (5), 11992552 (5), 9849855 (5), 12457032 (5) (see all 99)
    premalignant 74.3 238 8050814 (5), 7917902 (4), 12823203 (4), 9861340 (4) (see all 99)
    carcinoma ductal 73.8 193 20208478 (4), 17119686 (4), 16169726 (4), 10656439 (3) (see all 99)
    adenoma 73.8 1007 8062281 (9), 7704244 (8), 9924427 (7), 11812942 (7) (see all 99)
    somatic mutations 73.4 254 16337994 (4), 10471047 (3), 12203794 (3), 17200338 (3) (see all 99)
    astrocytoma 73.2 523 9839169 (8), 19428789 (8), 8293408 (7), 10063271 (7) (see all 99)
    ovarian carcinoma 72.8 431 12668287 (8), 7799045 (4), 11099323 (4), 10810396 (4) (see all 99)
    hepatocellular carcinoma 72.6 732 12800224 (6), 7689531 (6), 12772781 (6), 1332921 (5) (see all 99)
    endometrial carcinoma 72.4 411 16021509 (5), 8936111 (5), 8751556 (5), 8236823 (4) (see all 99)
    ovarian cancer 72.3 717 10560359 (8), 11733961 (7), 11309330 (7), 11774736 (7) (see all 99)
    papilloma 72.1 288 15638389 (5), 9178172 (4), 11404629 (4), 12597336 (4) (see all 99)
    cervical carcinoma 72 366 10374328 (7), 10813720 (6), 10072870 (6), 8630877 (5) (see all 99)
    carcinoma transitional cell 71.5 270 15825690 (4), 7796648 (4), 8217593 (4), 9720535 (3) (see all 99)
    glioma 71.4 893 11861384 (9), 8007011 (8), 18184456 (7), 10549925 (7) (see all 99)
    gastric carcinoma 71.2 470 11948492 (8), 7940194 (6), 12619111 (6), 8640663 (5) (see all 99)
    osteosarcoma 70.6 498 9891508 (7), 20459648 (6), 8781571 (6), 9492043 (6) (see all 99)
    lung carcinoma 70.2 245 11815976 (4), 10207632 (4), 12209756 (4), 8014012 (3) (see all 99)
    gastric cancer 69.9 793 19437562 (6), 12452062 (6), 10026322 (6), 10098768 (6) (see all 99)
    hnscc 69.8 246 18223210 (6), 18172861 (5), 18604737 (5), 17908957 (4) (see all 99)
    skin cancer 69.6 253 11429426 (4), 8625503 (4), 10190297 (4), 17270229 (4) (see all 99)
    aggressiveness 69.6 144 11484509 (2), 12777208 (2), 7697591 (2), 8892596 (2) (see all 99)
    anaplastic astrocytoma 69.6 109 9839169 (8), 1336544 (3), 8599254 (3), 8337939 (3) (see all 69)
    cervical cancer 69.4 477 16681751 (7), 14756543 (5), 10895031 (4), 12445252 (4) (see all 99)
    carcinoma endometrioid 69.4 88 8972476 (6), 8156496 (5), 9744308 (5), 11324501 (4) (see all 42)
    germ-line mutation 69.1 137 1631137 (4), 9005123 (3), 8527048 (3), 19674071 (3) (see all 88)
    colorectal tumors 68.6 112 8931611 (4), 8082516 (4), 9917132 (3), 16721749 (3) (see all 80)
    neoplastic transformation 68.3 98 8782209 (3), 9467348 (2), 10377949 (2), 8100854 (2) (see all 75)
    colon carcinoma 68.2 224 9731891 (5), 12525515 (3), 10644941 (3), 8054278 (3) (see all 99)
    laryngeal squamous cell carcinoma 67.8 109 9294474 (3), 18607961 (3), 12526287 (3), 15023836 (3) (see all 63)
    glioblastoma multiforme 67.7 84 8599254 (3), 9444787 (3), 1336544 (2), 15455376 (2) (see all 61)
    carcinoma non-small cell lung 67.7 101 11454718 (3), 8818693 (3), 7551299 (2), 8617082 (2) (see all 72)
    sarcoma 67.3 408 8821948 (7), 17136003 (6), 9140310 (5), 15618970 (5) (see all 99)
    bladder tumors 67 190 7869472 (6), 10492244 (5), 10355250 (4), 17085196 (4) (see all 99)
    allelic imbalance 66.4 87 7494603 (5), 18094375 (5), 16273227 (4), 11593417 (3) (see all 43)
    carcinoma intraepithelial 66.3 47 9306559 (4), 9683820 (4), 19543244 (4), 11444195 (2) (see all 22)
    neck cancer 64.7 215 15913883 (4), 18470731 (4), 10470224 (4), 11234882 (3) (see all 99)
    precancerous lesions 64.4 107 8608498 (3), 10875157 (2), 9769393 (2), 8895479 (2) (see all 68)
    oligodendroglioma 64.4 88 19781190 (5), 7714546 (5), 17319279 (5), 11907807 (4) (see all 45)
    oral cancer 64.3 196 17595776 (7), 10621843 (6), 12172574 (4), 14507241 (4) (see all 99)
    bladder carcinoma 64 147 7912753 (4), 15112266 (4), 7911381 (4), 16413663 (3) (see all 98)
    adenocarcinoma lung 63.9 155 8434702 (5), 11400116 (5), 16102896 (5), 12905708 (4) (see all 83)
    metaplasia 63.8 190 12172044 (5), 12655259 (5), 8253340 (5), 8647618 (4) (see all 99)
    lung tumor 63.7 203 12907609 (7), 10446974 (5), 15805253 (4), 9255578 (4) (see all 99)
    xeroderma pigmentosum 63.2 61 8319200 (3), 9622088 (2), 12242345 (2), 10354067 (2) (see all 43)
    malignant glioma 62.8 146 15960600 (5), 16278167 (5), 10584846 (4), 8682593 (4) (see all 68)
    familial adenomatous polyposis 61.6 94 1851662 (3), 15449054 (2), 1319835 (2), 8689171 (2) (see all 81)
    lymphoma 61.6 591 1466398 (7), 19650989 (6), 9662328 (6), 7661603 (5) (see all 99)
    pancreatic cancer 61 318 11075991 (5), 15810085 (5), 12561067 (5), 9869513 (5) (see all 99)
    carcinoma mucinous 60.6 47 16912910 (6), 19448592 (3), 10339657 (2), 10664332 (2) (see all 33)
    prostate cancer 60.2 728 18552821 (7), 8996359 (6), 14663467 (6), 7821906 (6) (see all 99)
    invasive cancer 60.2 54 18383208 (2), 8751330 (2), 7903288 (2), 9071897 (2) (see all 39)
    carcinoma adrenocortical 59.9 73 7978053 (3), 8509216 (2), 11454518 (2), 8640732 (2) (see all 48)
    carcinoma basal cell 59.6 138 17301441 (4), 16649377 (3), 11173659 (3), 11511317 (3) (see all 91)
    melanoma 59.3 791 8593106 (7), 10099830 (7), 7620345 (7), 9007946 (6) (see all 99)
    esophageal carcinoma 59.2 176 12168111 (6), 15386362 (5), 9028350 (5), 9813975 (4) (see all 82)
    brain tumors 58.9 152 17180249 (5), 7903434 (4), 10374339 (4), 9804370 (3) (see all 92)
    barrett esophagus 58.8 161 16416221 (5), 12823203 (5), 17982662 (5), 9649454 (4) (see all 76)
    thyroid carcinoma anaplastic 58.5 46 12364480 (3), 9038381 (3), 15650765 (2), 12370767 (2) (see all 31)
    chromosomal aberrations 58.4 134 16464797 (4), 10072601 (3), 7511286 (2), 9290953 (2) (see all 98)
    invasive ductal breast carcinoma 58.4 16 14645695 (2), 11380561 (2), 8291222 (1), 14511253 (1) (see all 13)
    endometrial cancer 58.3 180 19193430 (6), 15825182 (6), 15099969 (5), 15342458 (5) (see all 86)
    hyperplasia 58.1 262 9703382 (5), 8617483 (4), 8646368 (4), 11715068 (4) (see all 99)
    leukemia 57.9 380 12006509 (5), 9546437 (5), 1644930 (4), 8053492 (4) (see all 99)
    carcinoma transitional cell bladder 57.6 42 11471022 (3), 9275651 (2), 10687971 (2), 9891547 (2) (see all 27)
    carcinoma undifferentiated 57.5 41 8100564 (4), 8473515 (3), 8625287 (2), 8196165 (2) (see all 27)
    medulloblastoma 57.3 116 15717928 (6), 17180032 (5), 1873817 (4), 11212243 (4) (see all 50)
    epithelial tumor 57.2 75 16260276 (2), 8548593 (2), 7572785 (2), 7852189 (2) (see all 48)
    ductal breast carcinoma 56.8 22 11410327 (2), 10983725 (2), 8384406 (1), 8532697 (1) (see all 16)
    lymphoma b-cell 56.8 123 9262496 (5), 12911661 (4), 1375111 (3), 8220152 (3) (see all 76)
    laryngeal carcinoma 56.5 134 11699821 (6), 12600081 (5), 8386140 (4), 12815897 (4) (see all 65)
    lymphocytic leukemia chronic b-cell 56.5 49 1588788 (3), 7888675 (3), 8519411 (2), 8649796 (2) (see all 29)
    colon tumor 56.5 92 7586183 (5), 15729700 (4), 9065795 (3), 9097977 (3) (see all 54)
    small cell lung cancer 56.5 120 10582680 (3), 16158936 (3), 1648702 (3), 8103676 (3) (see all 81)
    solid tumor 56.3 98 9143413 (4), 9269965 (3), 19801892 (3), 15380594 (3) (see all 72)
    papillomavirus infections 55.9 57 9926893 (2), 9127380 (2), 7850072 (2), 7932807 (1) (see all 49)

    GeneTests: TP53
    Li-Fraumeni Syndrome

    Genetic Association Database (GAD): TP53
    Human Genome Epidemiology (HuGE) Navigator: TP53 (1074 documents)
    Tumor Gene Database (TGDB): TP53

    Export disorders for TP53 gene to outside databases

    (in PubMed. Associations of this gene to articles via 1Entrez Gene, 2UniProtKB/Swiss-Prot, 3HGNC, 4GAD, 5PharmGKB, 6HMDB, 7DrugBank, 8UniProtKB/TrEMBL, 9 Novoseek, and/or 10fRNAdb)
    About This Section

    PubMed articles for TP53 gene, integrated from 9 sources (see all 14923):
    (articles sorted by number of sources associating them with TP53)
        Utopia: connect your pdf to the dynamic
    world of online information

    1. Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. (PubMed id 6396087)1, 2, 3 Matlashewski G....Benchimol S. (1984)
    2. TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: association with risk factors and tumor characteristics. (PubMed id 12209590)1, 4, 9 Simao T.A....de Moura-Gallo C.V. (2002)
    3. Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family. (PubMed id 10484981)1, 2, 9 Gueran S.... Imirzalioglu N. (1999)
    4. Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. (PubMed id 19536131)1, 2, 9 Lee E.-W.... Song J. (2009)
    5. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. (PubMed id 8875929)1, 2, 9 Kussie P.H.... Pavletich N.P. (1996)
    6. Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population. (PubMed id 16314399)1, 4, 9 Ma H....Shen H. (2006)
    7. p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome. (PubMed id 16203772)1, 4, 9 Sotamaa K....de la Chapelle A. (2005)
    8. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. (PubMed id 12802680)1, 4, 9 Hwang S.J....Strong L.C. (2003)
    9. [p53 gene polymorphism with susceptibility to esophageal cancer and lung cancer in Chinese population] (PubMed id 12921568)1, 4, 9 Zhang J.H....He M. (2003)
    10. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. (PubMed id 16287156)1, 4, 9 Zhang X....Lin D. (2006)

    (in PubMed, OMIM, and NCBI Bookshelf)
    About This Section
     ANDOR
    Aliases
    Disorders
    Free Text  

      Query String
    PubMed
    OMIM
    NCBI Bookshelf
      (Note: In FireFox, select the above section and copy using Ctrl-C)

    (According to Entrez Gene, HGNC, AceView, euGenes, Ensembl, miRBase, ECgene, Kegg, and/or H-InvDB)
    About This Section
    Entrez Gene: 7157 HGNC: 11998 AceView: TP53 Ensembl:ENSG00000141510 euGenes: HUgn7157
    ECgene: TP53 Kegg: 7157 H-InvDB: TP53

    (According to HUGE)
    About This Section
      --

    (According to PharmGKB, ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL,
    Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot)
    About This Section
    NameDescription
    PharmGKB entry for TP53 Pharmacogenomics, SNPs, Pathways
    ATLAS Chromosomes in Cancer entry for TP53 Genetics and Cytogenetics in Oncology and Haematology
    IARC TP53 mutation databasehttp://www-p53.iarc.fr/
    The TP53 mutant web sitehttp://p53.fr/
    GeneReviewshttp://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/TP53
    NIEHS-SNPshttp://egp.gs.washington.edu/data/tp53/
    SHMPDhttp://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=TP53
    Wikipedia http://en.wikipedia.org/wiki/P53

    (Patent information from GeneIP,
    Licensable technologies from WIS Yeda, Salk, Tufts,
    IP news from LifeMap Sciences, Inc.)
    About This Section
    Patent Information for TP53 gene:
    Search GeneIP for patents involving TP53

    Licensable Technologies for TP53 gene:
    Weizmann Institute:
  • Treatment of Systemic Lupus Erythematosus by Down-Regulating the Autoimmune Response to Autoantigens
  •    (see first 1)
  • Immunogenic Compositions For Induction of Anti-Tumor Immunity
  •  Salk Institute: Assays for p53 Function in Cells
    GeneCards and IP:
    Japan Patent Office Licenses GeneCards     European Patent Office Licenses GeneCards     Improving the IP Search



    (Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, SABiosciences, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Uscn, Thermo Fisher Scientific, Gene Editing from DNA2.0, Clones from EMD Millipore, OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Cell lines from GenScript and LifeMap BioReagents, PCR Arrays from SABiosciences, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, and/or Enzo Life Sciences),
    In Situ Hybridization Assays from
    Advanced Cell Diagnostics
    About This Section

     Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
     EMD Millipore Mono- and Polyclonal Antibodies for the study of TP53
     EMD Millipore small molecules (inhibitor) for TP53
     EMD Millipore Kits and Assays for the Analysis of TP53
     EMD Millipore Purified and/or Recombinant TP53 Protein
     Browse for Gene Knock-down Tools from EMD Millipore
     
     EMD Millipore Custom Antibody & Bulk Services
     EMD Millipore Preclinical / Clinical Development Services
     EMD Millipore Immunoassay Services
     EMD Millipore Target Screening & Profiling Services

      
     Antibodies for TP53 (p53)   Browse Cell Culture Products  
     ELISAs for TP53 (p53)   Browse Flow Cytometry Kits  
     Browse Primer Pairs   Browse Kinase Activity Assays/Reagents  
     Browse ELISpot Kits/Development Modules   TFB/Immunoprecipitation Assays for TP53 (p53)  
     Browse Apoptosis Detection Kits/Reagents   Ubiquitin Proteasome Pathway (UPP) Assay Kits/Reagents for TP53 (p53)  
     Browse DNA Damage/Repair Kits/Reagents   Multiplex/Array Assay Kits/Reagents for TP53 (p53)  
     Browse Cell Selection/Detection Kits/Reagents   Browse Secondary Antibodies/Controls/Staining Reagents  
     Browse Phosphatase Activity Assays/Reagents   Recombinant/Natural Proteins for TP53 (p53)  
     OriGene Antibodies for TP53   OriGene shRNA RFP for TP53  
     OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for TP53   OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for TP53  
     OriGene Protein Over-expression Lysate for TP53   Browse OriGene Fluorogenic Cell Assay Kits  
     OriGene siRNA for TP53   OriGene 3'-UTR Clone for TP53  
     OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for TP53   OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for TP53  
     Browse OriGene GFP tagged cDNA clones in CMV expression vector   Browse OriGene MicroRNA Expression Plasmids  
     Browse OriGene basic RS shRNAs   Browse OriGene validated miRNA SYBR primer pairs  
     OriGene Purified Protein for TP53   OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling  
     OriGene Custom Antibody Services for TP53   OriGene Custom Protein Services for TP53  
     OriGene Custom Immunoassay Development  

     
     
     QIAGEN Custom miScript Target Protector blocks miRNA-binding site of in human, mouse, rat TP53
     QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing TP53
     QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat TP53
     QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat TP53
     Search QIAGEN QuantiFast Probe-based Assays in human, mouse, rat TP53
     QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat TP53
     GenScript Custom Purified and Recombinant Proteins Services for TP53 GenScript cDNA clones with any tag delivered in your preferred vector for TP53
     GenScript Custom Assay Services for TP53 GenScript Superior Antibodies for TP53
     GenScript Custom overexpressing Cell Line Services for TP53 CloneReady with Over 120,000 Genes
     Gene Synthesis: Any Gene in Any Vector Vector-based siRNA and miRNA, Ready for Transfection
     Gene Mutant Library, Variants up to 10^11 Plasmid Preparation
     Custom Peptide Services
     Antibodies & Assays for TP53  (p53)

     Regulatory tfbs in TP53 promoter
     Search Chromatin IP Primers for TP53
     RT2 qPCR Primer Assay in human, mouse, rat TP53
     GNC Network for TP53
     SABiosciences PCR Arrays including human, mouse, rat TP53
     Tocris compounds for TP53
     Browse Sino Biological Proteins and Antibodies
     cDNA Clones for TP53
     Antibodies/Proteins Production Services
     Rabbit Monoclonal Antibody Platform
     Bulk Purchasing
     Assays/Drugs/Proteins for TP53
     Search www.enzolifesciences.com for proteins, assays, substrates, inhibitors & antibodies
     Novus Tissue Slides
     TP53 antibodies
     TP53 proteins
     TP53 lysates
     Antibodies for TP53
     See all of Abcam's Antibodies, Kits and Proteins for TP53
     Custom Antibody / Protein Production Service
     Bulk Purchasing
     Advantages of Rabbit Monoclonal antibodies
     Abcam protocols and scientific support
     Recombinant Protein for TP53




     TP53 Proteins, Antibodies, CLIAs, and ELISAs
     Search LifeMap BioReagents cell lines for TP53
     Gene Synthesis
     Protein Engineering
     Variant Library Synthesis
     Codon Optimization
     Protein Production and Purification
     Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for TP53
     SwitchGear 3'UTR luciferase reporter plasmids for TP53
     SwitchGear Promoter luciferase reporter plasmids for TP53
     ThermoFisher Antibody for TP53
     Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat TP53
           
    GeneCards Homepage - Last full update: 18 Mar 2013 - Incrementals: 21 Mar 2013 , 15 Apr 2013 , 26 Apr 2013

    View Random Gene

    Category
    VWF
    (GIFTS: 73)
    von Willebrand factor
    GIFtS Group
    The GeneCards human gene database gene index: 1 3 5 6 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 


    Developed at the Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science

    Hot genes      Disease genes      TP53 gene at Home site.
    hostname: 356977-web1.xennexinc.com index build: 100 solr: 1.4